After the researchers adjusted their data for potential sources of bias, those differences narrowed
Yes, GLP-1 medications can cause fatigue in some patients, though it is not universal
The body contains more than 7,000 peptides
In patients who may be susceptible to the intracranial effects of CO2 retention (e.g., those with evidence of increased intracranial pressure or brain tumors), hydrocodone bitartrate and acetaminophen tablets may reduce respiratory drive, and the resultant CO2 retention can further increase intracranial pressure
Patients considering compounded tirzepatide should only obtain it from licensed pharmacies and under close medical supervision
The FDA has also warned about potential dosing errors with compounded GLP-1 products and has noted reports of compounders using salt forms (such as semaglutide sodium or semaglutide acetate) and adding other ingredients where safety and effectiveness have not been established